Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
2
Bearish filings
26
Named actors
10
Disclosed $ (bull / bear)
$199K / $48.8M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-13 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOANNE DONOVAN | filed notice to sell | $127K | SEC ↗ |
| 2026-07-01 | Chief Scientific Officer Russell Alan J | sold | $2.7M | SEC ↗ |
| 2026-07-01 | Chief Scientific Officer Russell Alan J | sold | $5.1M | SEC ↗ |
| 2026-07-01 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) ALAN J RUSSELL | filed notice to sell | $8.1M | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) JANUS HENDERSON GROUP PLC | disclosed a passive stake (13G) | — | SEC ↗ |
3 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-05-05 | CMO Donovan Joanne M. | sold | $1.9M | SEC ↗ |
| 2026-05-05 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOANNE DONOVAN | filed notice to sell | $1.6M | SEC ↗ |
| 2026-05-04 | CMO Donovan Joanne M. | sold | $164K | SEC ↗ |
| 2026-03-31 | CMO Donovan Joanne M. | sold | $685K | SEC ↗ |
| 2026-03-27 | CMO Donovan Joanne M. | sold | $209K | SEC ↗ |
| 2026-03-27 | CMO Donovan Joanne M. | sold | $298K | SEC ↗ |
| 2026-03-27 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOANNE DONOVAN | filed notice to sell | $2.3M | SEC ↗ |
| 2026-03-13 | Chief Scientific Officer and Director Alan Russell | adopted a selling plan | — | SEC ↗ |
| 2026-01-21 | Director Edris Badreddin | sold | $403K | SEC ↗ |
| 2026-01-21 | Director Edris Badreddin | sold | $224K | SEC ↗ |
| 2026-01-21 | Director Edris Badreddin | sold | $308K | SEC ↗ |
| 2026-01-21 | Director Edris Badreddin | sold | $2.0M | SEC ↗ |
| 2026-01-21 | Director Edris Badreddin | sold | $507K | SEC ↗ |
| 2026-01-21 | Director (via J.P. Morgan Securities LLC) Badreddin Edris | filed notice to sell | $3.4M | SEC ↗ |
| 2026-01-20 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT MICHAEL CARRUTHERS | filed notice to sell | $5.2M | SEC ↗ |
| 2026-01-15 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT MICHAEL CARRUTHERS | filed notice to sell | $4.8M | SEC ↗ |
| 2025-12-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT MICHAEL CARRUTHERS | filed notice to sell | $3.0M | SEC ↗ |
| 2025-12-26 | Chief Medical Officer Joanne Donovan | adopted a selling plan | — | SEC ↗ |
| 2025-11-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ROBERT MICHAEL CARRUTHERS | filed notice to sell | $1.6M | SEC ↗ |
| 2025-11-12 | Chief Scientific Officer Russell Alan J | sold | $2.1M | SEC ↗ |